S303 Treated Red Blood Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for S303 Treated Red Blood Cells, covering 2018-07-18 to 2018-07-18. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate Efficacy and Safety of S303 Treated Red Blood Cells (RBCs)in Subjects With Thalassemia Major Requiring Chronic RBC Transfusion [Phase 3]